🇺🇸 FDA
Patent

US 10314837

Subcutaneous delivery of poly(oxazoline) polymer conjugates

granted A61KA61K31/381A61K31/4045

Quick answer

US patent 10314837 (Subcutaneous delivery of poly(oxazoline) polymer conjugates) held by Serina Therapeutics, Inc. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/381, A61K31/4045, A61K31/4462, A61K31/4535